SPOTLIGHT: Levaquin approval expanded

SPOTLIGHT ON... Levaquin approval expanded
Johnson & Johnson's short-course antibiotic Levaquin got the FDA's approval as a treatment for stubborn urinary-tract infections and kidney infection. Release